Male | 0.79 (0.50 to 1.26) | 0.33 | | | 0.87 (0.45 to 1.67) | 0.68 | | |
Age (years) | 1.06 (1.03 to 1.08) | <0.001 | 1.03 (1.00 to 1.06) | 0.050 | 1.12 (1.06 to 1.17) | <0.001 | 1.13 (1.08 to 1.19) | <0.001 |
Education (years): | | <0.001 | | 0.016 | | 0.034 | | |
0–9 | 2.86 (1.54 to 5.31) | | 2.40 (1.18 to 4.88) | | 3.02 (1.14 to 8.00) | | | |
10–13 | 1.42 (0.73 to 2.76) | | 1.58 (0.78 to 3.19) | | 1.40 (0.44 to 4.41) | | | |
⩾14 | Reference | | | | Reference | | | |
“Blue collar” profession | 1.57 (1.00 to 2.46) | 0.052 | | | 1.66 (0.87 to 3.14) | 0.12 | | |
Delay to treatment (>4 months) | 0.81 (0.50 to 1.39) | 0.39 | | | 0.89 (0.46 to 1.73) | 0.74 | | |
Rheumatoid factor present | 1.10 (0.67 to 1.79) | 0.72 | | | 1.66 (0.77 to 3.61) | 0.20 | | |
Swollen joint count | 1.01 (0.98 to 1.05) | 0.49 | | | 1.00 (0.96 to 1.05) | 0.94 | | |
Tender joint count | 1.03 (1.00 to 1.06) | 0.031 | | | 1.02 (0.99 to 1.05) | 0.16 | | |
Global assessment: | | | | | | | | |
Patient’s assessment ⩾50 | 1.86 (1.18 to 2.94) | 0.008 | 1.77 (1.00 to 3.16) | 0.049 | 2.33 (1.23 to 4.43) | 0.010 | 2.07 (1.05 to 4.09) | 0.035 |
Physician’s assessment ⩾50 | 2.38 (1.48 to 3.82) | <0.001 | 1.85 (1.03 to 3.32) | 0.041 | 2.10 (1.13 to 3.88) | 0.019 | | |
ESR (mm/1st h) | 1.01 (1.00 to 1.02) | 0.028 | | | 1.01 (1.00 to 1.02) | 0.19 | | |
Erosive | 0.70 (0.44 to 1.10) | 0.12 | | | 0.71 (0.37 to 1.36) | 0.30 | | |
HAQ score ⩾1.0 | 1.96 (1.23 to 3.11) | 0.005 | 1.78 (1.01 to 3.14) | 0.046 | 2.09 (1.12 to 3.91) | 0.020 | 2.04 (1.09 to 3.82) | 0.026 |
Combination treatment | 0.55 (0.35 to 0.87) | 0.01 | 0.59 (0.35 to 0.99) | 0.047 | 0.64 (0.34 to 1.21) | 0.17 | | |